Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Biocartis Group NV
LSE:0R72

Watchlist Manager
Biocartis Group NV Logo
Biocartis Group NV
LSE:0R72
Watchlist
Price: 0.299 EUR 4% Market Closed
Market Cap: €162.9m
Write Note Create Alert Ask AI

Wall St Price Targets

0R72 Price Targets Summary
Biocartis Group NV

There are no price targets for 0R72.
0R72 Lowest Forecast
Wall Street Target
Not Available
0R72 Average Forecast
Wall Street Target
Not Available
0R72 Highest Forecast
Wall Street Target
Not Available
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Biocartis Group NV Competitors:
Price Targets
GRTX
Galera Therapeutics Inc
166% Upside
V
VIBHA
Vibhavadi Medical Center PCL
6% Upside
RVSB
Riverview Bancorp Inc
38% Upside
CBAN
Colony Bankcorp Inc
17% Upside
GRTX
Galera Therapeutics Inc
166% Upside
V
VIBHA
Vibhavadi Medical Center PCL
6% Upside
RVSB
Riverview Bancorp Inc
38% Upside
CBAN
Colony Bankcorp Inc
17% Upside
BBGI
Beasley Broadcast Group Inc
60% Upside

Revenue
Forecast

24% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
24% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 3 years is 21%.

What are analyst estimates?

Gross Profit
Forecast

18% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss
18% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss

Over the last 9 years, the compound annual growth rate for Gross Profit has been 18%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

What are analyst estimates?

Continue 0R72 Research

Summary
0R72 intrinsic value, competitors valuation, and company profile.
DCF Valuation
0R72 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
0R72 stock valuation using valuation multiples.
Wall St Estimates
0R72 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
0R72 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Biocartis Group NV listings:
F • EUR
8XB
 XBRU • EUR
BCART
 SWB • EUR
8XB
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0R72's stock price target?
Not Available

0R72 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Biocartis Group NV?
Projected CAGR
21%

Over the last 9 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 3 years is 21%.

Back to Top
ALPHA SPREAD
Follow us
Join 355,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett